These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1233 related articles for article (PubMed ID: 19801106)

  • 1. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can protons improve SBRT for lung lesions? Dosimetric considerations.
    Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
    Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
    Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.
    Dvorak P; Georg D; Bogner J; Kroupa B; Dieckmann K; Pötter R
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1572-81. PubMed ID: 15817364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
    Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
    Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
    Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets.
    Underberg RW; Lagerwaard FJ; Slotman BJ; Cuijpers JP; Senan S
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):554-60. PubMed ID: 15890600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer.
    Djärv E; Nyman J; Baumann P; Ekberg L; Høyer M; Lax I; Lewensohn R; Levin N; Lund JA; Morhed E; Ericsson SR; Traberg A; Wittgren L; Johansson KA
    Acta Oncol; 2006; 45(7):973-7. PubMed ID: 16982566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer.
    Arvidson NB; Mehta MP; Tomé WA
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1597-603. PubMed ID: 19028283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.
    Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ
    Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.
    Takeda A; Kunieda E; Sanuki N; Ohashi T; Oku Y; Sudo Y; Iwashita H; Ooka Y; Aoki Y; Shigematsu N; Kubo A
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):363-9. PubMed ID: 19427552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam.
    Koelbl O; Krieger T; Haedinger U; Sauer O; Flentje M
    Strahlenther Onkol; 2004 Dec; 180(12):783-8. PubMed ID: 15592698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
    Nichols RC; Huh SN; Henderson RH; Mendenhall NP; Flampouri S; Li Z; D'Agostino HJ; Cury JD; Pham DC; Hoppe BS
    Clin Lung Cancer; 2011 Jul; 12(4):252-7. PubMed ID: 21726825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.
    Onishi H; Kuriyama K; Komiyama T; Tanaka S; Sano N; Marino K; Ikenaga S; Araki T; Uematsu M
    Lung Cancer; 2004 Jul; 45(1):45-55. PubMed ID: 15196734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.